NUKETO® is a therapy for treatment of Chronic Kidney Disease(CKD) wherein patients are on conservative management especially when there is some residual kidney function left in stage I, II and III of Chronic Kidney Disease(CKD). NUKETO®, a combination of alpha keto amino acids and essential amino acids given to patients with very low protein or a low protein diet to delay the progression of CKD.
NUKETO® is indicated in prevention and therapy of damages due to faulty or deficient protein metabolism in chronic renal insufficiency
One tablet of NUKETO® per 5kg/body weight/day during meals every day for entire duration as prescribed by health care specialist.
NUKETO® in combination with very low protein/low protein diet helps in delaying the progression of CKD by preventing the degradation of body proteins, reducing urinary protein excretion and normalizing the carbohydrate metabolism.

Each NUKETO® tablet contains

Calcium 3-methy-2oxo-valerate (α-ketoanalogue of isoleucine,calcium salt) 67 mg
Calcium 4-methy-2oxo-valerate (α-ketoanalogue of leucine,calcium salt) 101 mg
Calcium-2-oxo-3-phenylpropionate (α-ketoanalogue of phenylalaline,calcium salt) 68 mg
Calcium-3-methyl-2-oxo-butyrate (α-ketoanalogue of valine,calcium salt) 86 mg
Calcium-DL-2-hydroxy-4(methylthio) butyrate (α-hydroxyanalogue of methionine,calcium salt) 59 mg
L-Lysine Acetate USP 105 mg
L-Threonine USP 53 mg
L-Tryptophan USP 23 mg
L-Histidine USP 38 mg
L-Tyrosine USP 30 mg
Total Nitrogen Content /Tablet 36 mg
Calcium Content/Tablet 1.25 mmol=^ 0.05 gm

The information given above is for general awareness and by no means intended to be seen as medical advice or replacement of medical advice. Please consult your health care specialist for medical advice.

× WhatsApp Us!